PromoCell supports researchers to study the mechanisms underlying SARS-CoV-2 infection by providing well characterised and standardised human primary cells isolated from the proximal and distal respiratory tract with matching specialty cell culture media, as well as a wide range of antibodies, blocking peptides and cell-based/drug screening assays for SARS and ACE2 research.
The PromoCell team of scientists will be with you for every research need or question you might have.
Airway Epithelial Cells and Media
Using human primary airway epithelial cells for infection studies with SARS-CoV-2 allows researchers to study how the virus interacts with its natural host. This contrasts with studying the virus in cell lines, which are often derived from tumour tissue and display modified gene and protein expression patterns. Cell lines are therefore unable to give a true insight into how SARS-CoV-2 interacts with human tissue.
Leading virology labs around the globe rely on PromoCell products for developing new strategies to fight COVID-19. Recent publications within the past few weeks by the labs of Pöhlmann (Göttingen, DE), Drosten (Charité, DE), Eils (Berlin Inst. of Health, DE), as well as Ingber (Boston, USA) featuring our products provide key insights on this matter.
Cell Analysis Tools to Study Respiratory & Infectious Diseases
Analysing and understanding the molecular mechanisms by which viruses infect mammalian cells and use them to proliferate, is decisive to develop new therapies as well as scientifically assessing and balancing risks and means in an emerging pandemy.
PromoCell provides a wide range of research tools to study viral/infectious and other respiratory diseases, including a variety of relevant antibodies, ELISAS & cytokines as well as reagents and assays to visualize cellular structures and determine cellular processes and pathways (e.g. cell viability/proliferation & cytotoxicity, cell metabolism & signalling, oxidative stress).